+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Shrimp Disease Diagnostics Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5017278
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Shrimp Disease Diagnostics Market grew from USD 478.10 million in 2024 to USD 517.54 million in 2025. It is expected to continue growing at a CAGR of 7.94%, reaching USD 756.45 million by 2030.

Shrimp disease diagnostics form the cornerstone of sustainable aquaculture, serving as an early warning system that protects both stock health and economic viability. As global demand for shrimp continues to escalate, producers face mounting pressure to ensure product safety, compliance with international trade regulations, and minimal environmental impact. Advancements in detection technologies and a shifting regulatory environment have elevated diagnostics from reactive measures to proactive strategies centered on continuous monitoring and early intervention. Decision-makers across farming operations, research institutions, and regulatory bodies now seek integrated diagnostic solutions that deliver rapid results, high accuracy, and scalable deployment.

Against this backdrop, the landscape of shrimp disease diagnostics is undergoing profound transformation. Where traditional biochemical tests once dominated, immunological and molecular methods are now gaining traction due to their sensitivity and specificity. Simultaneously, digital platforms for real-time data analysis and field-deployable testing kits are empowering frontline technicians. Yet with innovation comes complexity: navigating regulatory standards, managing supply chain disruptions, and integrating diverse diagnostic workflows require strategic foresight. This executive summary distills current trends, segmentation insights, regional dynamics, competitive landscapes, and actionable recommendations to guide stakeholders through this pivotal evolution.

Transformative Shifts in the Landscape

Over the past decade, the shrimp disease diagnostics sector has experienced transformative shifts driven by technological breakthroughs and evolving industry demands. Immunological diagnostics have expanded beyond enzyme-linked assays to include fluorescence-based lateral flow tests that accelerate on-site screening. Molecular diagnostics, once confined to centralized labs, now leverage portable PCR and next-generation sequencing platforms for in-field pathogen identification. Meanwhile, digital transformation has ushered in real-time monitoring software that integrates data from thermal cyclers, automated analyzers, and handheld microscopes, enabling holistic disease surveillance.

Regulatory frameworks have concurrently adapted, with authorities in major shrimp-producing regions mandating stringent testing protocols for export compliance and disease control. This regulatory tightening has incentivized end users-commercial farms, organic producers, consultancy firms, and academic labs-to adopt multiplex platforms capable of detecting bacterial, viral, fungal, and parasitic pathogens in a single workflow. As a result, collaborations between diagnostic vendors, biotechnology innovators, and data analytics firms are proliferating, fostering an ecosystem where hardware, software, and assay developers converge to deliver comprehensive solutions. These shifts underscore the sector’s progression toward integrated, agile, and high-throughput diagnostics that meet both production and public health imperatives.

Cumulative Impact of United States Tariffs 2025

In 2025, the imposition of new United States tariffs on imported diagnostic reagents and instruments has significantly impacted shrimp disease testing operations worldwide. Suppliers of automated analyzers, thermal cyclers, and lateral flow assay components have faced increased costs, prompting many to reassess their supply chains. Aquaculture enterprises reliant on qPCR and ELISA kits now encounter higher unit prices and extended lead times, affecting continuous monitoring and early detection programs that safeguard stock health.

These tariff pressures have spurred a surge in local manufacturing initiatives, with research laboratories and private facilities investing in domestically produced PCR assays and data analysis tools to mitigate import dependencies. In turn, diagnostic method providers are seeking partnerships with regional distributors to navigate tariff hurdles and maintain competitive pricing. Despite these headwinds, industry players continue to pursue disease surveillance and quality assurance testing aligned with export compliance standards. The net effect of the tariffs has been a recalibration of procurement strategies, increased focus on bench-top and portable platforms manufactured outside tariff jurisdictions, and renewed emphasis on cost-efficient diagnostic workflows that preserve operational resilience.

Key Segmentation Insights

Analysis of diagnostic method categories reveals that immunological techniques, including ELISA, immunofluorescence assays, lateral flow formats, and Western blot, are gaining share due to their rapid turnaround and ease of use in field environments. Molecular diagnostics-spanning PCR assays, qPCR assays, microarray analysis, and next-generation sequencing-are valued by research laboratories and consultancy firms for their unparalleled sensitivity and ability to characterize novel viral, bacterial, and fungal pathogens. Traditional diagnostics, comprising biochemical tests and morphological analysis, remain foundational in many academic institutions and small-scale farms where basic laboratory infrastructure prevails.

Regarding disease type, viral ailments such as white spot syndrome, infectious hypodermal and haematopoietic necrosis, taura syndrome, and yellowhead disease command extensive testing protocols due to their high mortality rates. Bacterial infections, notably Vibrio and necrotizing hepatopancreatitis, as well as fungal conditions like Fusarium diseases, continue to drive demand for routine surveillance. Parasitic threats, including microsporidia and nematode infections, prompt specialized assays in both commercial and organic production settings.

Detection technology segmentation highlights the growing adoption of hardware solutions such as automated analyzers, microscopes, and thermal cyclers, complemented by software platforms for real-time monitoring and advanced data analysis. End-user segmentation underscores that commercial shrimp farms and organic producers prioritize continuous monitoring programs, while consultancy firms and independent researchers leverage high-throughput bench-top systems. Academic institutions and private research facilities invest in modular and standalone bench-top platforms, whereas handheld devices and kit-based tests find favor in remote laboratories.

Finally, application segments such as aquaculture surveillance, food safety testing, and research and development each entail distinct diagnostic requirements. Continuous monitoring initiatives necessitate automated platforms for early detection, export compliance and shrimp quality assurance testing hinge on certified immunological and molecular assays, and disease pathogenesis studies or vaccine development projects rely on next-generation sequencing and comprehensive data analysis tools.

Key Regional Insights

Regional dynamics in shrimp disease diagnostics are shaped by production concentrations, regulatory regimes, and technological adoption rates. In the Americas, robust commercial farming operations in the United States, Mexico, and Latin America emphasize food safety testing aligned with export compliance to key international markets. Diagnostic providers in this region invest in portable platforms and real-time monitoring software that support continuous surveillance across large pond and recirculating aquaculture facilities.

Within Europe, the Middle East, and Africa, multidisciplinary research laboratories and consultancy firms collaborate closely with national authorities to address emerging viral and bacterial threats. High regulatory standards drive demand for multiplex immunological and molecular assays, while private research facilities in Western Europe invest heavily in next-generation sequencing and microarray analysis for vaccine development and pathogenesis studies.

The Asia-Pacific region remains the global epicenter of shrimp production, with countries such as China, India, Vietnam, and Thailand deploying comprehensive diagnostic workflows that span handheld kit-based tests at farm level to high-throughput bench-top platforms in central laboratories. This region’s dense production networks and history of disease outbreaks have accelerated adoption of qPCR assays, automated analyzers, and integrated data analysis tools to enable rapid detection and containment across both commercial shrimp farms and organic producers.

Key Company Insights

The competitive landscape in shrimp disease diagnostics features a diverse array of specialized firms and global powerhouses. Analytical instrument providers such as Thermo Fisher Scientific Inc. and Illumina, Inc. lead in next-generation sequencing platforms and high-throughput thermal cyclers, supporting critical research and vaccine development programs. Molecular assay developers including GeneReach Biotechnology Corp. and Mylab Discovery Solutions Pvt. Ltd. have pioneered portable PCR and qPCR tests that serve remote aquaculture sites.

Immunological diagnostics are advanced by companies like Randox Laboratories Ltd. and Speedy Assay Sdn. Bhd., which deliver ELISA kits and lateral flow formats tailored for food safety testing and export compliance. Hardware innovators such as 3 Little Fish Sdn Bhd and Aquaintech Inc. focus on automated analyzers and microscopes optimized for continuous monitoring, while real-time monitoring software is driven by firms including CD Genomics and Reagen LLC.

Regional specialists such as Arachem (M) Sdn Bhd and China Guangzhou BioKey Healthy Technology Co. Ltd. cater to local production hubs with modular bench-top systems and kit-based portable platforms. Contract research and private lab services are offered by Laboratory Corporation of America Holdings, DSM Austria GmbH, and GeneReach Biotechnology Corporation, supporting large-scale surveillance and pathogenesis studies. Innovative biotech startups like Speedy Assay Sdn. Bhd., PT Riset Nusantara Genetika (Nusantics), and Innocreate Bioscience Co., Ltd. are forging new pathways in data analytics, real-time pathogen monitoring, and vaccine development collaborations.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize a balanced portfolio of immunological, molecular, and traditional diagnostics to meet diverse end-user needs. Investing in modular bench-top platforms and handheld kit-based tests enhances flexibility for both centralized laboratories and field teams. Strategic partnerships with software developers will deliver integrated data analysis tools and real-time monitoring capabilities, crucial for rapid decision-making and early intervention.

Moreover, diversifying supply chains by engaging with regional manufacturers can offset the impact of import tariffs and minimize operational risks. Collaborating with academic institutions and private research facilities on next-generation sequencing and vaccine development projects strengthens disease pathogenesis insights, while joint ventures with portable platform developers accelerate deployment at the farm level.

Leaders should also implement continuous training programs for farm technicians, marine biologists, and laboratory staff to ensure proficiency in emerging diagnostic methods. Finally, aligning diagnostic strategies with regulatory standards for export compliance and food safety testing will safeguard market access and reinforce stakeholder confidence.

Conclusion

The shrimp disease diagnostics sector stands at a critical juncture where technological innovation, regulatory evolution, and global trade dynamics intersect. Stakeholders who integrate advanced immunological and molecular assays with real-time data analytics will gain a competitive edge in disease surveillance, food safety testing, and research applications. Embracing modular and portable platforms will ensure diagnostic agility, while robust partnerships across hardware, software, and assay providers will accelerate solution deployment.

By proactively addressing tariff challenges through supply chain diversification and regional manufacturing collaborations, organizations can maintain cost efficiencies and resilience. Continuous investment in skill development and cross-disciplinary research initiatives will further drive innovation in vaccine development and disease pathogenesis studies. Ultimately, a holistic approach to diagnostics-one that bridges traditional biochemical analyses with next-generation sequencing-will secure both shrimp health and industry sustainability.

Market Segmentation & Coverage

This research report categorizes the Shrimp Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Immunological Diagnostics
    • ELISA
    • Immunofluorescence Assays
    • Lateral Flow Assays
    • Western Blot
  • Molecular Diagnostics
    • Microarray Analysis
    • Next-Generation Sequencing
    • PCR Assays
    • qPCR Assays
  • Traditional Diagnostics
    • Biochemical Tests
    • Morphological Analysis
  • Bacterial Diseases
    • Necrotizing Hepatopancreatitis
    • Rickettsial Infections
    • Vibrio Infections
  • Fungal Diseases
    • Fusarium Diseases
    • Lagenidium Infections
  • Parasitic Diseases
    • Microsporidia Infections
    • Nematode Infections
  • Viral Diseases
    • Infectious Hypodermal and Haematopoietic Necrosis
    • Taura Syndrome
    • White Spot Syndrome
    • Yellowhead Disease
  • Hardware
    • Automated Analyzers
    • Microscopes
    • Thermal Cyclers
  • Software
    • Data Analysis Tools
    • Real-Time Monitoring Software
  • Aquaculture Enterprises
    • Commercial Shrimp Farms
    • Organic Shrimp Producers
  • Marine Biologists
    • Consultancy Firms
    • Independent Researchers
  • Research Laboratories
    • Academic Institutions
    • Private Research Facilities
  • Aquaculture Surveillance
    • Continuous Monitoring
    • Early Detection Programs
  • Food Safety Testing
    • Export Compliance
    • Shrimp Quality Assurance
  • Research and Development
    • Disease Pathogenesis Studies
    • Vaccine Development
  • Bench-Top Platforms
    • Modular Systems
    • Standalone Devices
  • Portable Platforms
    • Handheld Devices
    • Kit-Based Tests

This research report categorizes the Shrimp Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Shrimp Disease Diagnostics Market to delves into recent significant developments and analyze trends in each of the following companies:

  • 3 Little Fish Sdn Bhd
  • Amazing Biotech
  • Aquaintech Inc.
  • Arachem (M) Sdn Bhd
  • Bioneer Corporation
  • Blue Aqua International Pte. Ltd.
  • CD Genomics
  • China Guangzhou BioKey Healthy Technology Co. Ltd
  • DSM Austria GmbH
  • Forte Biotech
  • GeneReach Biotechnology Corp.
  • GeneReach Biotechnology Corporation
  • Genics Pty. Ltd.
  • Illumina, Inc.
  • Innocreate Bioscience Co., Ltd.
  • Lab-Ind Resource Sdn. Bhd.
  • Laboratory Corporation of America Holdings
  • Mahesh Aqua Holdings (Pvt) Ltd.
  • Mylab Discovery Solutions Pvt. Ltd.
  • PT Riset Nusantara Genetika (Nusantics)
  • Randox Laboratories Ltd.
  • Reagen LLC
  • Ring Biotechnology Co Ltd.
  • Speedy Assay Sdn. Bhd.
  • SUREBIO
  • Thermo Fisher Scientific Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Shrimp Disease Diagnostics Market, by Diagnostic Method
8.1. Introduction
8.2. Immunological Diagnostics
8.2.1. ELISA
8.2.2. Immunofluorescence Assays
8.2.3. Lateral Flow Assays
8.2.4. Western Blot
8.3. Molecular Diagnostics
8.3.1. Microarray Analysis
8.3.2. Next-Generation Sequencing
8.3.3. PCR Assays
8.3.4. qPCR Assays
8.4. Traditional Diagnostics
8.4.1. Biochemical Tests
8.4.2. Morphological Analysis
9. Shrimp Disease Diagnostics Market, by Disease Type
9.1. Introduction
9.2. Bacterial Diseases
9.2.1. Necrotizing Hepatopancreatitis
9.2.2. Rickettsial Infections
9.2.3. Vibrio Infections
9.3. Fungal Diseases
9.3.1. Fusarium Diseases
9.3.2. Lagenidium Infections
9.4. Parasitic Diseases
9.4.1. Microsporidia Infections
9.4.2. Nematode Infections
9.5. Viral Diseases
9.5.1. Infectious Hypodermal and Haematopoietic Necrosis
9.5.2. Taura Syndrome
9.5.3. White Spot Syndrome
9.5.4. Yellowhead Disease
10. Shrimp Disease Diagnostics Market, by Detection Technology
10.1. Introduction
10.2. Hardware
10.2.1. Automated Analyzers
10.2.2. Microscopes
10.2.3. Thermal Cyclers
10.3. Software
10.3.1. Data Analysis Tools
10.3.2. Real-Time Monitoring Software
11. Shrimp Disease Diagnostics Market, by End User
11.1. Introduction
11.2. Aquaculture Enterprises
11.2.1. Commercial Shrimp Farms
11.2.2. Organic Shrimp Producers
11.3. Marine Biologists
11.3.1. Consultancy Firms
11.3.2. Independent Researchers
11.4. Research Laboratories
11.4.1. Academic Institutions
11.4.2. Private Research Facilities
12. Shrimp Disease Diagnostics Market, by Application
12.1. Introduction
12.2. Aquaculture Surveillance
12.2.1. Continuous Monitoring
12.2.2. Early Detection Programs
12.3. Food Safety Testing
12.3.1. Export Compliance
12.3.2. Shrimp Quality Assurance
12.4. Research and Development
12.4.1. Disease Pathogenesis Studies
12.4.2. Vaccine Development
13. Shrimp Disease Diagnostics Market, by Test Platform
13.1. Introduction
13.2. Bench-Top Platforms
13.2.1. Modular Systems
13.2.2. Standalone Devices
13.3. Portable Platforms
13.3.1. Handheld Devices
13.3.2. Kit-Based Tests
14. Americas Shrimp Disease Diagnostics Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Shrimp Disease Diagnostics Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Shrimp Disease Diagnostics Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. 3 Little Fish Sdn Bhd
17.3.2. Amazing Biotech
17.3.3. Aquaintech Inc.
17.3.4. Arachem (M) Sdn Bhd
17.3.5. Bioneer Corporation
17.3.6. Blue Aqua International Pte. Ltd.
17.3.7. CD Genomics
17.3.8. China Guangzhou BioKey Healthy Technology Co. Ltd
17.3.9. DSM Austria GmbH
17.3.10. Forte Biotech
17.3.11. GeneReach Biotechnology Corp.
17.3.12. GeneReach Biotechnology Corporation
17.3.13. Genics Pty. Ltd.
17.3.14. Illumina, Inc.
17.3.15. Innocreate Bioscience Co., Ltd.
17.3.16. Lab-Ind Resource Sdn. Bhd.
17.3.17. Laboratory Corporation of America Holdings
17.3.18. Mahesh Aqua Holdings (Pvt) Ltd.
17.3.19. Mylab Discovery Solutions Pvt. Ltd.
17.3.20. PT Riset Nusantara Genetika (Nusantics)
17.3.21. Randox Laboratories Ltd.
17.3.22. Reagen LLC
17.3.23. Ring Biotechnology Co Ltd.
17.3.24. Speedy Assay Sdn. Bhd.
17.3.25. SUREBIO
17.3.26. Thermo Fisher Scientific Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. SHRIMP DISEASE DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. SHRIMP DISEASE DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. SHRIMP DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DETECTION TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DETECTION TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TEST PLATFORM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TEST PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. SHRIMP DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. SHRIMP DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SHRIMP DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PCR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY QPCR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MORPHOLOGICAL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY NECROTIZING HEPATOPANCREATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RICKETTSIAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIBRIO INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUSARIUM DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY LAGENIDIUM INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MICROSPORIDIA INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY NEMATODE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS HYPODERMAL AND HAEMATOPOIETIC NECROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TAURA SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY WHITE SPOT SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY YELLOWHEAD DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY THERMAL CYCLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REAL-TIME MONITORING SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE ENTERPRISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COMMERCIAL SHRIMP FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ORGANIC SHRIMP PRODUCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MARINE BIOLOGISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY CONSULTANCY FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT RESEARCHERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MARINE BIOLOGISTS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PRIVATE RESEARCH FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY CONTINUOUS MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY EARLY DETECTION PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY EXPORT COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SHRIMP QUALITY ASSURANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE PATHOGENESIS STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TEST PLATFORM, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BENCH-TOP PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MODULAR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STANDALONE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BENCH-TOP PLATFORMS, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PORTABLE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT-BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PORTABLE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MARINE BIOLOGISTS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TEST PLATFORM, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BENCH-TOP PLATFORMS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PORTABLE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MARINE BIOLOGISTS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TEST PLATFORM, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BENCH-TOP PLATFORMS, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PORTABLE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MARINE BIOLOGISTS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TEST PLATFORM, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BENCH-TOP PLATFORMS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PORTABLE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 158. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 159. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 160. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 161. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 162. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 163. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, 2018-2030 (USD MILLION)
TABLE 164. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, 2018-2030 (USD MILLION)
TABLE 165. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, 2018-2030 (USD MILLION)
TABLE 166. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, 2018-2030 (USD MILLION)
TABLE 167. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 169. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 170. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 172. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MARINE BIOLOGISTS, 2018-2030 (USD MILLION)
TABLE 173. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 174. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 176. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 177. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 178. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TEST PLATFORM, 2018-2030 (USD MILLION)
TABLE 179. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BENCH-TOP PLATFORMS, 2018-2030 (USD MILLION)
TABLE 180. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PORTABLE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 181. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 182. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 183. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 184. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 185. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 186. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, 2018-2030 (USD MILLION)
TABLE 187. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, 2018-2030 (USD MILLION)
TABLE 188. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, 2018-2030 (USD MILLION)
TABLE 189. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, 2018-2030 (USD MILLION)
TABLE 190. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 192. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 193. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 195. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MARINE BIOLOGISTS, 2018-2030 (USD MILLION)
TABLE 196. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 197. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 199. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 200. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 201. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TEST PLATFORM, 2018-2030 (USD MILLION)
TABLE 202. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BENCH-TOP PLATFORMS, 2018-2030 (USD MILLION)
TABLE 203. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PORTABLE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MARINE BIOLOGISTS, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TEST PLATFORM, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BENCH-TOP PLATFORMS, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PORTABLE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MARINE BIOLOGISTS, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TEST PLATFORM, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BENCH-TOP PLATFORMS, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PORTABLE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MARINE BIOLOGISTS, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TEST PLATFORM, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BENCH-TOP PLATFORMS, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PORTABLE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 275. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 276. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 277. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 278. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 279. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 280. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, 2018-2030 (USD MILLION)
TABLE 281. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, 2018-2030 (USD MILLION)
TABLE 282. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, 2018-2030 (USD MILLION)
TABLE 283. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, 2018-2030 (USD MILLION)
TABLE 284. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 286. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 287. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE ENTERPRISES, 2018-2030 (USD MILLION)
TABLE 289. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MARINE BIOLOGISTS, 2018-2030 (USD MILLION)
TABLE 290. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 291. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE SURVEILLANCE, 2018-2030 (USD MILLION)
TABLE 293. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FOOD SAFETY TESTING, 2018-2030 (USD MILLION)
TABLE 294. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 295. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TEST PLATFORM, 2018-2030 (USD MILLION)
TABLE 296. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BENCH-TOP PLATFORMS, 2018-2030 (USD MILLION)
TABLE 297. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PORTABLE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 298. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
TABLE 299. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 300. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 301. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 302. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 303. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, 2018-2030 (USD MILLION)
TABLE 304. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, 2018-2030 (USD MILLION)
TABLE 305. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, 20

Companies Mentioned

  • 3 Little Fish Sdn Bhd
  • Amazing Biotech
  • Aquaintech Inc.
  • Arachem (M) Sdn Bhd
  • Bioneer Corporation
  • Blue Aqua International Pte. Ltd.
  • CD Genomics
  • China Guangzhou BioKey Healthy Technology Co. Ltd
  • DSM Austria GmbH
  • Forte Biotech
  • GeneReach Biotechnology Corp.
  • GeneReach Biotechnology Corporation
  • Genics Pty. Ltd.
  • Illumina, Inc.
  • Innocreate Bioscience Co., Ltd.
  • Lab-Ind Resource Sdn. Bhd.
  • Laboratory Corporation of America Holdings
  • Mahesh Aqua Holdings (Pvt) Ltd.
  • Mylab Discovery Solutions Pvt. Ltd.
  • PT Riset Nusantara Genetika (Nusantics)
  • Randox Laboratories Ltd.
  • Reagen LLC
  • Ring Biotechnology Co Ltd.
  • Speedy Assay Sdn. Bhd.
  • SUREBIO
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...